CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study

التفاصيل البيبلوغرافية
العنوان:	CD8⁺ CD28⁻ regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
المؤلفون:	Kriegsmann, Katharina^{Aff1, Aff2}, Ton, Gigi Nu Hoang Quy, Awwad, Mohamed H. S., Benner, Axel, Bertsch, Uta^{Aff1, Aff4}, Besemer, Britta, Hänel, Mathias, Fenk, Roland, Munder, Markus, Dürig, Jan, Blau, Igor W., Huhn, Stefanie, Hose, Dirk, Jauch, Anna, Mann, Christoph, Weinhold, Niels, Scheid, Christof, Schroers, Roland, von Metzler, Ivana, Schieferdecker, Aneta, Thomalla, Jörg, Reimer, Peter, Mahlberg, Rolf, Graeven, Ullrich, Kremers, Stephan, Martens, Uwe M., Kunz, Christian, Hensel, Manfred, Seidel-Glätzer, Andrea, Weisel, Katja C., Salwender, Hans J., Müller-Tidow, Carsten^{Aff1, Aff4, Aff27}, Raab, Marc S., Goldschmidt, Hartmut^{Aff1, Aff4}, Mai, Elias K., Hundemer, Michael^{Aff1, IDs4137502402290y_cor36}
المصدر:	Leukemia. 38(7):1621-1625
قاعدة البيانات:	Springer Nature Journals

كن أول من يترك تعليقا!